Tel Aviv University’s technology transfer company Ramot, announced recently, that it has signed a collaboration agreement with Bayer, a German pharmaceutical multinational, to develop and test new cardiac drugs using 3D printed human heart tissues.
Tel Aviv University’s technology transfer company Ramot, announced recently, that it has signed a collaboration agreement with Bayer, a German pharmaceutical multinational, to develop and test new cardiac drugs using 3D printed human heart tissues.